01:33 AM EDT, 10/22/2026 (MT Newswires) -- Galderma Group (GALD.SW) posted $1.63 billion in net sales for the third quarter, compared with $1.29 billion a year ago, it said Thursday. The Swiss dermatology group's net sales growth was attributed to all product categories and better-than-expected market conditions. For 2026, annual net sales growth guidance was raised to the range of 22.5% to 23.5% at constant currency from 19% to 21% previously.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.